Comparison of adequacy of anaesthesia monitoring with standard clinical practice monitoring during routine general anaesthesia: An international, multicentre, single-blinded randomised controlled trial.
Journal
European journal of anaesthesiology
ISSN: 1365-2346
Titre abrégé: Eur J Anaesthesiol
Pays: England
ID NLM: 8411711
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
20
10
2020
medline:
28
4
2021
entrez:
19
10
2020
Statut:
ppublish
Résumé
Previous studies have suggested that monitoring the levels of both hypnosis and antinociception could reduce periods of inadequate anaesthesia. However, the evidence regarding associated benefits of this monitoring is still limited. The primary objective of this study was to confirm that guidance of anaesthesia by depth of hypnosis and antinociception monitoring decreases the number of inadequate anaesthesia events in comparison with standard clinical practice. A multicentre, single-blinded, randomised controlled trial. The study was conducted in four European University hospitals in four different countries between December 2013 and November 2016. The study population consisted of a total of 494 adult patients undergoing elective surgery requiring tracheal intubation. The patients were allocated to one of two groups. The first group was treated using Entropy for depth of hypnosis and surgical pleth index to determine depth of antinociception (adequacy of anaesthesia group; AoA group). The second group was monitored using standard monitoring alone (control group). Anaesthesia was conducted with target-controlled infusions of propofol and remifentanil. The primary outcome of the study was the number of total unwanted events for example signs of inadequately light or unintentionally deep anaesthesia. Evidence of inadequate anaesthesia had an incidence of around 0.7 events per patient in both groups with no difference between groups (P = 0.519). In the AoA group, the overall consumption of propofol was significantly reduced (6.9 vs. 7.5 mg kg h, P = 0.008) in comparison with the control group. The consumption of remifentanil was equal in both groups. The times to emergence [8.0 vs. 9.6 min (P = 0.005)] and full recovery in the postanaesthesia care unit (P = 0.043) were significantly shorter in the AoA group. No differences were seen in postoperative pain scores or in the use of analgesics. In the current study, the guidance of total intravenous anaesthesia by Entropy and surgical pleth index in comparison with standard monitoring alone was not able to validate reduction of unwanted anaesthesia events. However, there was a reduction in the use of propofol, and shorter times for emergence and time spent in the postanaesthesia care unit. at ClinicalTrials.gov NCT01928875.
Sections du résumé
BACKGROUND
Previous studies have suggested that monitoring the levels of both hypnosis and antinociception could reduce periods of inadequate anaesthesia. However, the evidence regarding associated benefits of this monitoring is still limited.
OBJECTIVE
The primary objective of this study was to confirm that guidance of anaesthesia by depth of hypnosis and antinociception monitoring decreases the number of inadequate anaesthesia events in comparison with standard clinical practice.
DESIGN
A multicentre, single-blinded, randomised controlled trial.
SETTING
The study was conducted in four European University hospitals in four different countries between December 2013 and November 2016.
PATIENTS
The study population consisted of a total of 494 adult patients undergoing elective surgery requiring tracheal intubation.
INTERVENTIONS
The patients were allocated to one of two groups. The first group was treated using Entropy for depth of hypnosis and surgical pleth index to determine depth of antinociception (adequacy of anaesthesia group; AoA group). The second group was monitored using standard monitoring alone (control group). Anaesthesia was conducted with target-controlled infusions of propofol and remifentanil.
MAIN OUTCOME MEASURES
The primary outcome of the study was the number of total unwanted events for example signs of inadequately light or unintentionally deep anaesthesia.
RESULTS
Evidence of inadequate anaesthesia had an incidence of around 0.7 events per patient in both groups with no difference between groups (P = 0.519). In the AoA group, the overall consumption of propofol was significantly reduced (6.9 vs. 7.5 mg kg h, P = 0.008) in comparison with the control group. The consumption of remifentanil was equal in both groups. The times to emergence [8.0 vs. 9.6 min (P = 0.005)] and full recovery in the postanaesthesia care unit (P = 0.043) were significantly shorter in the AoA group. No differences were seen in postoperative pain scores or in the use of analgesics.
CONCLUSION
In the current study, the guidance of total intravenous anaesthesia by Entropy and surgical pleth index in comparison with standard monitoring alone was not able to validate reduction of unwanted anaesthesia events. However, there was a reduction in the use of propofol, and shorter times for emergence and time spent in the postanaesthesia care unit.
TRIAL REGISTRATION
at ClinicalTrials.gov NCT01928875.
Identifiants
pubmed: 33074943
doi: 10.1097/EJA.0000000000001357
pmc: PMC7792984
doi:
Substances chimiques
Anesthetics, Intravenous
0
Propofol
YI7VU623SF
Banques de données
ClinicalTrials.gov
['NCT01928875']
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
73-81Références
Eur J Anaesthesiol. 2014 Feb;31(2):76-84
pubmed: 24284309
Minerva Anestesiol. 2015 May;81(5):480-9
pubmed: 25032676
Br J Anaesth. 2014 May;112(5):898-905
pubmed: 24535604
Br J Anaesth. 2002 Jul;89(1):156-66
pubmed: 12173227
Acta Anaesthesiol Scand. 2009 Sep;53(8):975-85
pubmed: 19572939
Cochrane Database Syst Rev. 2016 Oct 18;10:CD007272
pubmed: 27755648
J Clin Monit Comput. 2018 Aug;32(4):771-778
pubmed: 28856631
Acta Anaesthesiol Scand. 2008 Sep;52(8):1038-45
pubmed: 18840101
Medicine (Baltimore). 2016 Aug;95(35):e4743
pubmed: 27583920
Br J Anaesth. 2008 Sep;101(3):383-9
pubmed: 18628266
Br J Anaesth. 2009 Oct;103(4):586-93
pubmed: 19648155
Br J Anaesth. 2013 Apr;110(4):622-8
pubmed: 23220856
Br J Anaesth. 2016 Sep;117(3):358-64
pubmed: 27543530
Anesthesiology. 2015 Jun;122(6):1280-7
pubmed: 25815454
Br J Anaesth. 2010 May;104(5):587-95
pubmed: 20354006
Cochrane Database Syst Rev. 2014 Jun 17;(6):CD003843
pubmed: 24937564
Minerva Anestesiol. 2017 Feb;83(2):200-213
pubmed: 27807964
Anesth Analg. 2010 Mar 1;110(3):765-72
pubmed: 20185655
Anaesthesia. 2012 May;67(5):508-13
pubmed: 22324319
Anesthesiology. 2010 May;112(5):1175-83
pubmed: 20418698
Anaesthesia. 2007 Dec;62(12):1224-9
pubmed: 17991257
Health Technol Assess. 2013 Aug;17(34):1-264
pubmed: 23962378
Br J Anaesth. 2007 Apr;98(4):456-61
pubmed: 17350969
Cochrane Database Syst Rev. 2016 Mar 14;3:CD010135
pubmed: 26976247
Br J Anaesth. 2007 Sep;99(3):359-67
pubmed: 17609248
Anesthesiology. 2005 Aug;103(2):274-9
pubmed: 16052109
Br J Anaesth. 2007 Apr;98(4):447-55
pubmed: 17329347
Anesthesiol Res Pract. 2010;2010:
pubmed: 20700429
Acta Anaesthesiol Scand. 2004 Feb;48(2):145-53
pubmed: 14995935